UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016947
Receipt number R000019671
Scientific Title Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drug
Date of disclosure of the study information 2015/04/01
Last modified on 2020/04/05 19:29:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drug

Acronym

Effect of the Integrated Approach to Symptom Management for skin toxicity associated with molecularly targeted drug

Scientific Title

Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drug

Scientific Title:Acronym

Effect of the Integrated Approach to Symptom Management for skin toxicity associated with molecularly targeted drug

Region

Japan


Condition

Condition

skin toxicity associated with molecularly targeted drug

Classification by specialty

Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the effect of the Integrated Approach to Symptom Management (IASM) for the patients who has skin toxicity associated with molecularly targeted drug. The guide book ver.9 for nurse's activity will be used.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

skin condition (adverse events of skin)

Key secondary outcomes

self-efficacy scale for cancer patients
Skindex29
self-care ability (scale)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Period: to March 31st 2016
Frequency : 4 times
First Intervention:
1)Interview according to guide book. Conduct observation of skin condition. Measure the outcome scales.
2)Understand the symptom experience of the patient and feedback it empathically.
3)Assessment of self-care ability.
4)Share the plan of the intervention.
5)Provide essential knowledge, essential skill, essential nursing support. (use the original pamphlet)
6)Patients will record their symptom and care for themselves.

Second and Third Intervention:
1)Listen and understand patient's symptom experience.
2)Positive feedback.
3)Practice the above 3)4)5).

Final Intervention:
1)Review and share the process for 6 weeks.
2)Recognize and identify patient's effort and make sure their achievement.
3)Measure the outcome scales.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Out patients who have skin toxicity associated with Epidermal growth factor receptor (EGFR) inhibitors or multikinase inhibitors.
2) Patients who have the ability to communicate in Japanese and to respond to the questionnaire without any cognitive disability.

Key exclusion criteria

Patients who cannot communicate in Japanese and be described to understand the contents of the questionnaire.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Atsuko Uchinuno

Organization

University of Hyogo

Division name

College of Nursing

Zip code


Address

13-71 Kitaouji-cho,Akashi,Hyogo,673-8588 JAPAN

TEL

078-925-9435

Email

a_uchinuno@cnas.u-hyogo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masamichi Fukuda

Organization

University of Hyogo

Division name

College of Nursing

Zip code


Address

13-71 Kitaouji-cho,Akashi,Hyogo,673-8588 JAPAN

TEL

078-925-9434

Homepage URL

http://sm-support.net/

Email

masamichi_fukuda@cnas.u-hyogo.ac.jp


Sponsor or person

Institute

University of Hyogo

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the promotion of Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都第二赤十字病院(京都府)、兵庫県立がんセンター(兵庫県)、神戸市医療センター(兵庫県)、姫路医療センター(兵庫県)、兵庫県立塚口病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 04 Month 01 Day

Date of IRB

2015 Year 06 Month 01 Day

Anticipated trial start date

2015 Year 06 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 03 Month 27 Day

Last modified on

2020 Year 04 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019671


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name